Nuwellis (NUWE) Surges

Small-cap Healthcare company Nuwellis has logged a 3.8% change today on a trading volume of 2,286,751. The average volume for the stock is 63,675.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Based in Eden Prairie, United States the company has 70 full time employees and a market cap of $3,682,891.

The company is now trading -94.61% away from its average analyst target price of $216.67 per share. The 3 analysts following the stock have set target prices ranging from $75 to $300, and on average give Nuwellis a rating of buy.

Over the last year, NUWE shares have gone down by -91.8%, which represents a difference of -77.9% when compared to the S&P 500. The stock's 52 week high is $185 per share and its 52 week low is $9.55. Based on Nuwellis's average gross margin growth of 34.7% over the last four years, its core business remains strong and the stock price may recover in the long term.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.